SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-24-001331
Filing Date
2024-01-16
Accepted
2024-01-16 10:34:45
Documents
18
Period of Report
2024-01-16

Document Format Files

Seq Description Document Type Size
1 6-K a240116_6kxmorxvotingright.htm 6-K 10973
2 EX-99.1 exhibit_991.htm EX-99.1 5069
3 EX-99.2 exhibit_992.htm EX-99.2 6575
4 EX-99.2 exhibit_993.htm EX-99.2 5067
5 GRAPHIC exhibit_991001.jpg GRAPHIC 118040
6 GRAPHIC exhibit_991002.jpg GRAPHIC 125889
7 GRAPHIC exhibit_991003.jpg GRAPHIC 127829
8 GRAPHIC exhibit_991004.jpg GRAPHIC 52572
9 GRAPHIC exhibit_992001.jpg GRAPHIC 115924
10 GRAPHIC exhibit_992002.jpg GRAPHIC 123169
11 GRAPHIC exhibit_992003.jpg GRAPHIC 119707
12 GRAPHIC exhibit_992004.jpg GRAPHIC 88429
13 GRAPHIC exhibit_992005.jpg GRAPHIC 101139
14 GRAPHIC exhibit_992006.jpg GRAPHIC 31180
15 GRAPHIC exhibit_993001.jpg GRAPHIC 118052
16 GRAPHIC exhibit_993002.jpg GRAPHIC 125575
17 GRAPHIC exhibit_993003.jpg GRAPHIC 127870
18 GRAPHIC exhibit_993004.jpg GRAPHIC 52547
  Complete submission text file 0001628280-24-001331.txt   1996504
Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Filer) CIK: 0001340243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38455 | Film No.: 24534056
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)